Pathway Medical Technologies developed medical devices for the treatment of arterial disease. The company's initial focus was treating peripheral arterial disease more quickly, safely and effectively than existing technologies. Acquired by MEDRAD, Inc., an affiliate of Bayer HealthCare, in August 2011.